Sharp John P

Ligand Pharmaceuticals Inc.

VP Finance and CFO

Avg. Two Year Performance

No Purchase Track Record

(24%) Avg. Sale Return (11%) Compound

Holdings: 17.67K shares

Last Three Months: 26-Aug-24 -- 25-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions